Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept

Joint Bone Spine

Volumn 80, Issue 6, 2013, Pages 660-663

  Michel, Murielle ^a   Henri, Patrick ^a   Vincent, Fabien B ^b   Leon, Nathalie ^a   Marcelli, Christian ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Abatacept; Biological therapy; Cytotoxic T lymphocyte antigen 4 (CTLA4) Immunoglobulin; Glomerulonephritis; Immunoglobulin (Ig)A; Rheumatoid arthritis (RA)

Indexed keywords

ABATACEPT; ADALIMUMAB; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; IMMUNOGLOBULIN A; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; ANTIBODY CONJUGATE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENERALIZED LYMPHADENOPATHY; HEMATURIA; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; KIDNEY BIOPSY; LEUKOCYTE COUNT; MICROSCOPY; MONOTHERAPY; NEUTROPHIL COUNT; PROTEINURIA; PURPURIC RASH; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINALYSIS; ARTHRITIS, RHEUMATOID; CHEMICALLY INDUCED; GLOMERULONEPHRITIS; IMMUNOLOGY; MIDDLE AGED;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN A; MIDDLE AGED;

EID: 84888439589     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.05.003     Document Type: Article

References (15)

1. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365:2205-2219.
2. Korpela M., Mustonen J., Teppo A.M., et al. Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol 1997, 36:1189-1195.
3. Prete M., Racanelli V., Digiglio L., et al. Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev 2011, 11:123-131.
4. Schiff M. Abatacept treatment for rheumatoid arthritis. Rheumatology (Oxford) 2011, 50:437-449.
5. Fiocco U., Sfriso P., Oliviero F., et al. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev 2008, 8:76-82.
6. Vincent F.B., Morand E.F., Murphy K., et al. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Ann Rheum Dis 2013, 72:165-178.
7. Asahina A., Ohshima N., Nakayama H., et al. Henoch-Schonlein purpura in a patient with rheumatoid arthritis receiving etanercept. Eur J Dermatol 2010, 20:521-522.
8. D'Amico G., Napodano P., Ferrario F., et al. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int 2001, 59:682-692.
9. Roux C.H., Brocq O., Albert C.B.V., et al. Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis. Joint Bone Spine 2004, 71:444-445.
10. Saint Marcoux B., De Bandt M. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 2006, 73:710-713.
11. Stokes M.B., Foster K., Markowitz G.S., et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 2005, 20:1400-1406.
12. Exarchou S.A., Voulgari P.V., Markatseli T.E., et al. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol 2009, 38:328-331.
13. Fiorentino D.F. The Yin and Yang of TNF-{alpha} inhibition. Arch Dermatol 2007, 143:233-236.
14. Marinchev L., Atanasova S., Robeva R., et al. Diffuse mesangial IgA glomerulonephritis in a patient with rheumatoid arthritis: a possible extra-articular manifestation in rheumatoid arthritis. BMJ Case Rep 2009, 2009. 10.1136/bcr.07.2008.0394.
15. Gorgi Y., Sfar I., Goucha R., et al. [IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients]. Tunis Med 2010, 88:789-793.